uniQure (QURE) Other Working Capital Changes (2016 - 2017)
uniQure (QURE) posted quarterly Other Working Capital Changes of -$31.6 million for Q4 2020, down 1877.44% year-over-year from $1.8 million in Q1 2020, and down 6447.72% quarter-over-quarter from -$482000.0 in Q3 2020.
Analysis
uniQure (QURE) Other Working Capital Changes (2016 - 2017) Analysis & Trends
uniQure's Other Working Capital Changes history runs 4 years deep, the most recent figure standing at -$31.6 million for Q4 2020.
- In Q4 2020, Other Working Capital Changes fell 1877.44% year-over-year to -$31.6 million; the TTM figure through Dec 2020 stood at -$33.6 million (down 572.97% YoY), while the FY2020 annual figure was -$33.6 million, down 572.97% from the prior year.
- Other Working Capital Changes for Q4 2020 stood at -$31.6 million, down from -$482000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was -$1.0 million in Q4 2016, with the low at -$16.3 million in Q3 2017.
- The 4-year median for Other Working Capital Changes is -$1.7 million (2019), against an average of -$4.3 million.
- Peak annual rise in Other Working Capital Changes reached 150.28% in 2020, while the deepest fall reached 1877.44% in 2020.
- uniQure's Other Working Capital Changes stood at -$1.5 million in 2017, then gained by 9.47% to -$1.3 million in 2018, then decreased by 20.91% to -$1.6 million in 2019, then slumped by 1877.44% to -$31.6 million in 2020.
- Business Quant data shows QURE's Other Working Capital Changes at -$31.6 million in Q4 2020, -$482000.0 in Q3 2020, and -$1.9 million in Q2 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | -1.46 Mn |
| Dec 31, 2017 | -1.46 Mn |
| Sep 30, 2017 | -16.31 Mn |
| Sep 30, 2017 | -16.31 Mn |
| Jun 30, 2017 | -2.05 Mn |
| Jun 30, 2017 | -2.05 Mn |
| Mar 31, 2017 | -1.27 Mn |
| Mar 31, 2017 | -1.27 Mn |
| Dec 31, 2016 | -1.05 Mn |
| Dec 31, 2016 | -1.05 Mn |
| Sep 30, 2016 | -1.76 Mn |
| Sep 30, 2016 | -1.76 Mn |
| Jun 30, 2016 | -1.47 Mn |
| Jun 30, 2016 | -1.47 Mn |
| Mar 31, 2016 | -1.42 Mn |
| Mar 31, 2016 | -1.42 Mn |